“Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?” (2020) Journal of Renal and Hepatic Disorders, 4(1), pp. 18–21. doi:10.15586/jrenhep.2020.68.